Table 3.
Medications Use at Discharge and Follow‐Up Among Black and White Patients
| All (n=919) | Black (n=203) | White (n=716) | P Value | |
|---|---|---|---|---|
| Medications at discharge | ||||
| DAPT | 915 (99.6) | 200 (98.5) | 715 (99.9) | 0.97 |
| Aspirin+clopidogrel | 612 (66.6) | 134 (66.0) | 478 (66.8) | |
| Aspirin+prasugrel or ticagrelor | 303 (33.0) | 66 (32.5) | 237 (33.1) | |
| Statins | 839 (91.6) | 188 (92.6) | 651 (91.3) | 0.55 |
| β‐Blocker | 779 (85.0) | 172 (84.7) | 607 (85.1) | 0.89 |
| ACEI/ARB | 624 (67.9) | 139 (68.5) | 485 (67.7) | 0.85 |
| Proton pump inhibitor | 350 (38.1) | 76 (37.4) | 274 (38.3) | 0.96 |
| Oral anticoagulants | 101 (11.0) | 13 (6.4) | 88 (12.3) | 0.02 |
| Medications at time of event or last follow‐up | ||||
| DAPT | 821 (89.7) | 175 (86.3) | 646 (90.8) | 0.89 |
| Aspirin+clopidogrel | 604 (66.0) | 128 (63.1) | 476 (66.9) | |
| Aspirin+prasugrel or ticagrelor | 217 (23.7) | 47 (23.2) | 170 (23.9) | |
| Statins | 833 (91.0) | 185 (91.1) | 648 (91.0) | 0.96 |
| β‐Blocker | 524 (57.3) | 100 (49.3) | 424 (59.6) | 0.009 |
| ACEI/ARB | 610 (66.7) | 134 (66.0) | 476 (66.9) | 0.82 |
| Proton pump inhibitor | 368 (40.2) | 75 (36.9) | 293 (41.1) | 0.31 |
| Oral anticoagulants | 95 (10.3) | 13 (6.4) | 82 (11.4) | 0.03 |
Data are shown as n (%). ACEI/ARB indicates angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker; DAPT, dual antiplatelet therapy.